# Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years

> **NCT01511250** · PHASE2 · COMPLETED · sponsor: **Takeda** · enrollment: 360 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** TDV
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT01511250
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11-16
- **Primary completion:** 2016-04-01
- **Final completion:** 2016-04-15
- **Target enrollment:** 360 (ACTUAL)
- **Last updated:** 2023-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01511250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01511250, "Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01511250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*